# The Use of Autologous Mesenchymal Stem Cell Preparation for Treatment of Refractory Migraine

> **NCT04064879** · NA · SUSPENDED · sponsor: **Neurological Associates of West Los Angeles** · enrollment: 10 (actual)

## Conditions studied

- Chronic Migraine, Headache

## Interventions

- **OTHER:** AD-SVF

## Key facts

- **NCT ID:** NCT04064879
- **Lead sponsor:** Neurological Associates of West Los Angeles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-08-16
- **Primary completion:** 2023-08-15
- **Final completion:** 2023-08-16
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Pending FDA approval
- **Last updated:** 2022-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04064879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04064879, "The Use of Autologous Mesenchymal Stem Cell Preparation for Treatment of Refractory Migraine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04064879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*